Visceral Fat Calculator

Is Your Belly Fat Dangerous?

Visceral fat wraps around your organs and drives diabetes, heart disease, and hormonal imbalance — even at a normal weight. Find your risk level in 30 seconds.

Visceral Fat Tool

Visceral Fat & Metabolic Risk Calculator

Enter your measurements — results appear instantly with your full risk profile

Sex

Age

yrs

Height

Weight

lbs

Waist at navel level

Hip widest point

—

Visceral Fat Level

—

Waist-to-Height Ratio

—

HealthyElevatedHighVery High

What This Means

—

What Is Visceral Fat?

Unlike subcutaneous fat (the fat under your skin), visceral fat wraps around your internal organs and is metabolically active in ways that damage your health.

Step 1

Cardiovascular Risk

Visceral fat releases inflammatory cytokines directly into the portal vein — the blood vessel supplying the liver. This drives systemic inflammation that damages blood vessels and raises cardiovascular disease risk.

Step 2

Type 2 Diabetes

Visceral fat interferes with insulin signaling in the liver and muscles, producing insulin resistance — the primary driver of type 2 diabetes. Reducing visceral fat by 5–10% measurably improves insulin sensitivity.

Step 3

Hormonal Disruption

In men, visceral fat converts testosterone to estrogen through aromatase enzyme activity, lowering testosterone levels by up to 30%. In women, it worsens insulin resistance in PCOS, disrupting ovulatory function.

Step 4

Why BMI Misses It

Visceral fat accumulation is poorly reflected by BMI. A person at a normal BMI can carry dangerously high visceral fat (called "normal-weight obesity"). Waist-to-height ratio is validated to detect this. BMI cannot.

Medical Disclaimer: This visceral fat calculator provides estimates based on waist-to-height ratio and published population reference data. Calculations are for informational purposes only and do not constitute medical or clinical assessment. Individual variation in fat distribution means estimates may not reflect actual visceral fat levels in all individuals. Consult a licensed healthcare provider for clinical evaluation of metabolic risk. Compounded semaglutide and tirzepatide at AHC are not FDA-approved finished products. All prescriptions are issued by independently licensed U.S. healthcare providers following individual patient evaluations.

Also try: Body Fat Calculator · TDEE Calculator · BMI Calculator

Start Your Personalized Plan For Visceral Fat Calculation Today

Take control of how you age with science-driven treatments designed to restore energy, clarity, and vitality.

Waist-to-Height Ratio Risk Categories

Based on BMC Medicine 2014 systematic review and U.S. Marine Corps 2026 fitness standards.

WHtR Range	Risk Category	Health Implication
Below 0.40	Underweight Risk	Possible muscle or bone mass deficit; consult a physician
0.40 – 0.49	Healthy	Low visceral fat risk; healthy central adiposity
0.50 – 0.59	Elevated Risk	Elevated cardiovascular and metabolic risk; intervention recommended
0.60 – 0.69	High Risk	Significant metabolic syndrome risk; medical evaluation strongly recommended
0.70 and above	Very High Risk	Severe central obesity; urgent medical evaluation recommended

Keep your waist circumference below half your height. Above 0.5, cardiovascular and metabolic risk increases significantly.

0.5 The is the Critical Threshold

FAQs — Visceral Fat Calculator

How do I know if I have too much visceral fat?

The most accessible non-invasive method is waist-to-height ratio: divide your waist circumference by your height in the same unit. A ratio of 0.50 or above indicates elevated visceral fat risk. The clinical gold standard is a DEXA scan or abdominal CT scan, which measures visceral fat area directly. Bioelectrical impedance scales that report visceral fat levels (Tanita, Omron) provide a practical home monitoring option.

Is waist-to-height ratio better than BMI?

Yes, for assessing visceral fat risk. A 2014 systematic review in BMC Medicine of over 300,000 adults concluded that waist-to-height ratio is a better screening tool than BMI or waist circumference alone for cardiovascular disease and type 2 diabetes risk. BMI cannot differentiate between muscle mass and fat mass, and does not detect where fat is stored. Waist-to-height ratio specifically measures central adiposity — where fat is most metabolically dangerous.

What is a dangerous visceral fat level?

On the Tanita visceral fat scale (1–59), levels above 12 are considered high. On the simplified 1–12 scale used in this calculator and common in consumer health devices, levels 6–8 indicate elevated risk and levels 9–12 indicate high to very high risk. A waist-to-height ratio above 0.50 correlates with elevated visceral fat at clinically meaningful levels — this is the most accessible threshold to monitor without equipment.

Does GLP-1 therapy reduce visceral fat?

Yes, and tirzepatide appears to preferentially reduce visceral fat compared to subcutaneous fat. Clinical trial data and imaging studies show that GLP-1 and dual GIP/GLP-1 therapy produce disproportionately large reductions in visceral adipose tissue relative to total weight loss. This is particularly relevant for patients whose primary health risk comes from visceral fat rather than overall BMI — a very common profile for people with type 2 diabetes risk, PCOS, or metabolic syndrome.

How quickly can visceral fat be reduced?

Visceral fat is among the most responsive fat types to calorie deficit and exercise interventions. Research shows that even 5–8% body weight loss produces measurable reductions in visceral fat area on imaging. With GLP-1 therapy producing 15–22% body weight loss at therapeutic doses, the visceral fat reductions are clinically substantial — often improving metabolic syndrome markers, insulin sensitivity, and hormonal balance within 3–6 months.

Visceral Fat Responds Powerfully to GLP-1 Therapy

Tirzepatide at AHC produces average weight loss of 22.5% — with documented preferential reduction in visceral fat. Physician-supervised programs from $169/month.